Selected Publications

  1. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Akerstrom G, Melhus H. 1995. Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Medicine. 1:1309-11.
  2. Carling T, Ridefelt P, Hellman P, Rastad J, Åkerström G. 1997. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab. 82:1772-1775.
  3. Carling T, Åkerström G, Rastad J, Westin G. 1998. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab. 83:2255-2259.
  4. Carling T, Correa P, Hedberg J, et al. 1998. Parathyroid MEN1 gene mutations in relation to clinical charactersistics of non-familial primary hyperparathyroidism. J Clin Endocrinol Metab. 83:2960-2963.
  5. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Akerstrom G, Westin G.1998. Mutation in the MEN1 gene in non-familial malignant endocrine pancreatic tumors. Cancer Res. 58:377-379.
  6. Correa P, Rastad J, Schwarz P, Westin G, Kindmark A, Lundgren E, Åkerström G, Carling T. 1999. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and relation to parathyroid VDR mRNA levels. J Clin Endocrinol Metab. 84: 1690-1694.
  7. Carling T, Imanishi Y, Gaz RD, Arnold A. 1999. Analysis of the rad54 gene on chromosome 1p as a potential tumor suppressor gene in parathyroid adenomas. Int J Cancer. 24;83:80-2.
  8. Carling T, Imanishi Y, Gaz RD, Arnold A. 1999 Expression and sequence analysis of rad51: a candidate tumor suppressor gene on chromosome 15q in a region frequently deleted in parathyroid tumors. Clin Endo. 51:403-408.
  9. Carling T, Szabo E, Bai M, , et al. 2000. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab. 85: 2042-2047.
  10. Carling T, Rastad J, Szabo E, Westin G, Åkerström G. 2000. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in hyperparathyroidism. J Clin Endocrinol Metab. 85:2000-2003.
  11. Steele-Perkins G, Fang W, Yang, X.-H., Van Gele, M., Gu, J., Carling, T, et al. 2001. Tumor formation and inactivation of RIZ1, a Rb-binding member of the PR/SET nuclear protein methyltransferase superfamily. Genes & Dev. 15:2250-2262.
  12. Du Y, Carling T, Fang W, Piao Z, Sheu J-C, Huang S. 2001. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily Cancer Research. 61: 8094-8099.
  13. Correa P, Juhlin C, Rastad J, Westin G, Åkerström G, Carling T. 2001. Allelic loss in clinically and screening-detected primary hyperparathyroidism. Clin Endocrinology. 56: 113-7.
  14. Carling T. 2001. Molecular pathology of parathyroid tumors. Trends Endocrinol & Metab. 12, 53-58.
  15. Correa P, Lundgren E, Rastad J, Åkerström G, Westin G, Carling T. 2002. The MEN1 gene polymorphism D418D is associated with sporadic primary hyperparathyroidism. Surgery. 132: 450-5.
  16. Szabo E, Carling T, Hessman O, Rastad J, 2002. Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalcuria and point mutation in the calcium receptor. J Clin Endocrinol Metab. 87: 3961-5.
  17. Villablanca A, Höög A, Smith T, Wassif WS, Vierimaa O, Kassem M, Dwight T, Forsberg L, Du Q, Learoyd D, Jones K, Tean BT, Carling T, Robinsson B, Larsson C. 2002. Involvement of the MEN1 gene locus in familial isolated hyperparathyrodism (FIHP). Eur J Endocrinol. 147: 313-22.
  18. Carling T, Kim KC, Yang XH, Gu J, Zhang XK, Huang S. 2004. A histone methyltransferase is required for maximal response to female sex hormones. Mol Cell Biol. 16:7032-42.
  19. Grundberg E., Carling T., Brändström H., Huang S., Ribom E. L., Ljunggren Ö., Mallmin H., Kindmark A. 2004. A deletion polymorphism in the RIZ gene, a female sex steroid hormone receptor coactivator, exhibits decreased response to estrogen in vitro and associates with low bone mineral density in young Swedish women. J Clin Endocrinol Metab. 89: 6173-8.
  20. Carling T. 2005. Multiple Endocrine Neoplasia Syndrome - Genetic Basis for Clinical Management. Current Opinion in Oncology. 17:7-12.
  21. Carling T, Udelsman R. 2005. Parathyroid surgery in familial hyperparathyroid disorders. Journal of Internal Medicine. 257: 27-37.
  22. Geli J, Nord B, Frisk T, Edstrom Elder E, Ekstrom TJ, Carling T, Backdahl M, Larsson C. 2005. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. Int J Oncol 26: 1385-91.
  23. Carling T, Ocal IT, & Udelsman R. 2007. Special Variants of Differentiated Thyroid Cancer: Does it Alter the Extent of Surgery vs. Well Differentiated Thyroid Cancer? World Journal of Surgery. 5:916-23.
  24. Carling T, Udelsman R. 2008. Thyroid Tumors. In Cancer: Principles & Practice of Oncology, 8th edition Editors, DeVita, Jr. V.T., Lawrence, TS., Rosenberg S.A. Lippincott-Raven. Philadelphia.